Dosage Forms

Jennifer Markarian is manufacturing editor of BioPharm International.

Articles

A device manufacturing process must be carefully designed in the early stages of development to ensure success in commercial manufacturing. 

Manufacturing Drug–Device Combination Products 

Inovio received a $71-million contract from the US Department of Defense to scale up manufacture of its Cellectra smart device to deliver its DNA vaccine.

Inovio to Scale-Up Manufacture of Intradermal Delivery Device for its COVID-19 Vaccine

Hallie Forcinio is packing editor for Pharmaceutical Technology and Pharmaceutical Technology Europe, editorhal@sbcglobal.net.

New options for pharmaceutical tubes enhance functionality, sustainability, and brand identity. 

Pharma Packaging Focus on Tubes

Evonik opened a new facility for GMP manufacturing of bioresorbable polymers and excipients for pharmaceutical and medical applications in Birmingham, AL.

Evonik Commissions US Facility for Bioresorbable Polymers and adds CMO Services

Jennifer Markarian is manufacturing editor of Pharmaceutical Technology.

Equipment and process optimization must be considered for scaling up these developmental technologies to commercial production.

Manufacturing Microneedle Array Patches for Vaccine Delivery

Understanding of scale-up parameters and use of process analytical technology are important to meet demand for larger batch sizes.

Challenges in Clinical Manufacturing for Topical Drugs

Trends affecting primary pharmaceutical packaging include the shift to more complex drug-device combination products.

Primary Packaging for Combination Products

PATH’s Microarray Patch Center of Excellence aims to accelerate transdermal patch technology for public health needs.

Advancing Transdermal Drug Delivery

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Several factors must be considered when reformulating APIs for pediatric, geriatric, and other specialty patient populations.

Adapting APIs for Specialty Dosage Forms

Regulatory, cultural, and technical differences between drug and device development can pose challenges to pharmaceutical combination product development.

Specialty Dosage Drugs